Inhibition of CatS in patients with primary Sjögren syndrome using selective inhibitor RO5459072 resulted in decreased T-cell response toward autoantigens (SS-A, soluble substance A and SS-B, soluble substance B) and suppressed cytokine secretion by CD14+ monocytes [35]. This evidence concerns the gene PIMREG and Sjogren syndrome.